{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Caixin China Biz Roundup: Chinese mRNA Jab Activates 80% to 95% Immune Response","description":"Behind the findings of the homegrown shot\u2019s first stage clinical trials; Beijing\u2019s plan to stay smog-free over the Olympics; and China digests a record amount of bad assets.  Are you a big fan of our shows? Then please give our podcast account, China Business Insider, a 5-star rating on Spotify, Apple, or wherever you listen to podcasts! ","author_name":"China Business Insider -  News From Caixin Global","author_url":"https:\/\/www.caixinglobal.com\/audio\/","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/21901646\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/21901646"}